Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kobinger GP"'
Autor:
de La Vega MA; Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Polychronopoulou E; Office of Biostatistics, University of Texas Medical Branch, Galveston, TX, USA., Xiii A; Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Ding Z; Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China., Chen T; Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China., Liu Q; Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People's Republic of China.; University of Chinese Academy of Sciences, Beijing, People's Republic of China., Lan J; Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People's Republic of China., Nepveu-Traversy ME; Global Urgent and Advanced Research and Development (GuardRX), Batiscan, Canada., Fausther-Bovendo H; Global Urgent and Advanced Research and Development (GuardRX), Batiscan, Canada., Zaidan MF; Department of Internal Medicine, Division of Pulmonary, Critical Care, & Sleep Medicine, University of Texas Medical Branch, Galveston, TX, USA., Wong G; Viral Hemorrhagic Fevers Research Unit, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People's Republic of China., Sharma G; Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA., Kobinger GP; Galveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Publikováno v:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (1), pp. e2169198.
Autor:
Jelinski J; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Kowatsch MM; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada., Lafrance MA; Faculty of Medicine, Université Laval, Quebec City, Canada., Berger A; Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, Canada., Pedersen J; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec, Canada., Azizi H; Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, Canada., Li Y; Department of Microbiology and Immunology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Canada., Scholte F; Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, Canada., Gomez A; Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, Canada., Hollett N; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada., Le T; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada., Wade M; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec, Canada., Fausther-Bovendo H; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., de La Vega MA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Babuadze G; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Xiii A; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Lamarre C; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec, Canada., Racine T; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec, Canada., Kang CY; Department of Microbiology and Immunology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Canada., Yao XJ; Department of Medical Microbiology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada., Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Arts E; Department of Microbiology and Immunology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Canada., Fowke KR; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada., Kobinger GP; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Publikováno v:
Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (2), pp. 2251595.
Autor:
Racine T; Department of Medical Microbiology, University of Manitoba , Winnipeg , Manitoba , Canada.; Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec, Université Laval , Québec City , Québec , Canada., Kobinger GP; Department of Medical Microbiology, University of Manitoba , Winnipeg , Manitoba , Canada.; Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec, Université Laval , Québec City , Québec , Canada.; Department of Immunology, University of Manitoba , Winnipeg , Manitoba , Canada.; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine , Philadelphia , PA , USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2019; Vol. 15 (10), pp. 2264-2268. Date of Electronic Publication: 2019 Apr 23.
Autor:
Wong G; a Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious Diseases, Shenzhen Key Laboratory of Pathogen and Immunity , Shenzhen Third People's Hospital , Shenzhen , China.; b CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology , Chinese Academy of Sciences , Beijing , China.; c National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , MB , Canada.; d Department of Medical Microbiology , University of Manitoba , Winnipeg , MB , Canada., Mendoza EJ; c National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , MB , Canada.; e Department of Immunology , University of Manitoba , Winnipeg , MB , Canada., Plummer FA; d Department of Medical Microbiology , University of Manitoba , Winnipeg , MB , Canada., Gao GF; a Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious Diseases, Shenzhen Key Laboratory of Pathogen and Immunity , Shenzhen Third People's Hospital , Shenzhen , China.; f National Institute for Viral Disease Control and Prevention , Chinese Center for Disease Control and Prevention (China CDC) , Beijing , China., Kobinger GP; c National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , MB , Canada.; d Department of Medical Microbiology , University of Manitoba , Winnipeg , MB , Canada.; e Department of Immunology , University of Manitoba , Winnipeg , MB , Canada.; g Department of Pathology and Laboratory Medicine , University of Pennsylvania School of Medicine , Philadelphia , PA , USA.; h Département de microbiologie-infectiologie et d'immunologie , Université Laval , Québec , Canada., Qiu X; c National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , MB , Canada.; d Department of Medical Microbiology , University of Manitoba , Winnipeg , MB , Canada.
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2018 Feb; Vol. 18 (2), pp. 159-173. Date of Electronic Publication: 2017 Nov 17.
Autor:
Kozak RA; a Special Pathogens Program, National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , Canada.; b Department of Medical Microbiology , University of Manitoba , Winnipeg , Canada., Kobinger GP; a Special Pathogens Program, National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , Canada.; b Department of Medical Microbiology , University of Manitoba , Winnipeg , Canada.; c Department of Pathology and Laboratory Medicine , University of Pennsylvania School of Medicine , Philadelphia , PA , USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2016 Sep; Vol. 15 (9), pp. 1093-100. Date of Electronic Publication: 2016 Apr 12.
Autor:
de La Vega MA; a Special Pathogens Program, National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , Canada.; b Department of Immunology , University of Manitoba , Winnipeg , Canada., Bello A; a Special Pathogens Program, National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , Canada., Chaillet P; c Laboratory services , Médecins Sans Frontières , Brussels , Belgium., Kobinger GP; a Special Pathogens Program, National Microbiology Laboratory , Public Health Agency of Canada , Winnipeg , Canada.; b Department of Immunology , University of Manitoba , Winnipeg , Canada.; d Department of Medical Microbiology , University of Manitoba , Winnipeg , Canada.; e Department of Pathology and Laboratory Medicine , University of Pennsylvania School of Medicine , Philadelphia , PA , USA.
Publikováno v:
Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2016 Jun; Vol. 14 (6), pp. 557-67. Date of Electronic Publication: 2016 May 13.
Autor:
Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street Winnipeg, MB, R3E 3R2 Canada., Kobinger GP, Qiu X
Publikováno v:
Expert review of clinical immunology [Expert Rev Clin Immunol] 2014 Jun; Vol. 10 (6), pp. 781-90. Date of Electronic Publication: 2014 Apr 18.
Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?.
Autor:
Fausther-Bovendo H; a National Microbiology Laboratory ; Public health Agency of Canada ; Winnipeg , MB Canada., Kobinger GP
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2014; Vol. 10 (10), pp. 2875-84.
Autor:
Qiu X; National Microbiology Laboratory; Public Health Agency of Canada; Winnipeg, MB Canada., Kobinger GP; National Microbiology Laboratory; Public Health Agency of Canada; Winnipeg, MB Canada; Department of Medical Microbiology; University of Manitoba; Winnipeg, MB Canada; Department of Immunology; University of Manitoba; Winnipeg, MB Canada; Department of Pathology and Laboratory Medicine; University of Pennsylvania School of Medicine; Philadelphia, PA USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2014; Vol. 10 (4), pp. 964-7. Date of Electronic Publication: 2014 Feb 06.
Autor:
Dong JC; Special Pathogens Program; National Microbiology Laboratory; Public Health Agency of Canada; Winnipeg, MB Canada; Department of Immunology; University of Manitoba; Winnipeg, MB Canada., Kobinger GP
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2013 Apr; Vol. 9 (4), pp. 808-11. Date of Electronic Publication: 2013 Apr 01.